Masimo Corporation (MASI)
-NasdaqGS 21.84 
0.19(0.88%) May 23, 4:00PM EDT|After Hours
:
21.90 0.06 (0.27%) May 23, 4:57PM EDT
| Prev Close: | 21.65 |
|---|
| Open: | 21.68 |
|---|
| Bid: | 19.08 x 200 |
|---|
| Ask: | 22.97 x 500 |
|---|
| 1y Target Est: | 24.07 |
|---|
| Beta: | 0.92 |
|---|
| Next Earnings Date: | 31-Jul-13 |
|---|
| Day's Range: | 21.40 - 22.00 |
|---|
| 52wk Range: | 18.20 - 25.35 |
|---|
| Volume: | 281,318 |
|---|
| Avg Vol (3m): | 392,095 |
|---|
| Market Cap: | 1.24B |
|---|
| P/E (ttm): | 20.22 |
|---|
| EPS (ttm): | 1.08 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- El Paso Children's Hospital Standardizes to Masimo SET® Pulse OximetryPR Newswire(Thu, May 23)
- Study Shows Noninvasive SpCO® Can Help Rapidly Detect Carbon Monoxide Poisoning in the Emergency DepartmentPR Newswire(Tue, May 21)
- Masimo CEO Joe Kiani Receives Argyros Medal for Visionary Leadership & Commitment to Patient SafetyPR Newswire(Mon, May 20)
- New Clinical Study Finds Masimo rainbow® Acoustic Monitoring™ Technology More Accurately, Precisely, and Reliably Detects Ventilatory Pauses in Post-Surgical PatientsPR Newswire(Thu, May 16)
- [video] Ratings Moves: CDI, IMO, MASIat TheStreet(Wed, May 15)
- MASIMO CORP FinancialsEDGAR Online Financials(Wed, May 15)
- Masimo announces clinical study results for company's noninvansive PVIat theflyonthewall.com(Wed, May 15)
- New Published Clinical Study Shows Masimo PVI® Helps Clinicians Assess Fluid Responsiveness in Pediatric PatientsPR Newswire(Wed, May 15)
- Masimo Corporation Stock Upgraded (MASI)at TheStreet(Wed, May 15)
- Masimo Wins a Major Turkish ClientZacks(Mon, May 13)
- New Clinical Studies Presented at the International Anesthesia Research Society Annual Meeting Show Benefits of Masimo Noninvasive Patient Monitoring Technologies: SpHb®, RRa™, and SedLine®PR Newswire(Mon, May 13)
- MASIMO CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 8)
- Uludag University Hospital Installs Masimo Noninvasive rainbow® Technology to Improve Patient Assessments and Speed Clinical DecisionsPR Newswire(Wed, May 8)
- FDA Clears Masimo rainbow® Acoustic Monitoring™ Sensor for Use on Pediatric PatientsPR Newswire(Mon, May 6)
- Why Masimo Shares Jumpedat Motley Fool(Fri, May 3)
Key Statistics
| Forward P/E (1 yr): | 17.90 |
|---|
| P/S (ttm): | 2.41 |
|---|
| Ex-Dividend Date: | 23-Nov-12 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.14 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.28 |
|---|
| Mean Recommendation*: | 2.7 |
|---|
| PEG Ratio (5 yr expected): | 1.31 |
|---|
Business Summary
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology (SET), which provides the capabilities of measure-throu...
View More